연구동향 분석

A paradigm shift in studies based on rheumatoid arthritis clinical registries

조수경 성윤경 2019년

논문상세정보
인용/피인용
' A paradigm shift in studies based on rheumatoid arthritis clinical registries' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Arthritis
  • Big data
  • Patients reported outcomes
  • cohortstudies
  • registries
  • rheumatoid
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,045 0

0.0%

' A paradigm shift in studies based on rheumatoid arthritis clinical registries' 의 참고문헌

  • 류마티스 질환의 코호트 연구
    조수경 [2014]
  • Using technology to support clinical care and research in rheumatoid arthritis
    Dixon WG [2018]
  • Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy : data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study
  • Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis : a nationwide population-based cohort study
    Raaschou P [2018]
  • The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28
    Sato M [2006]
  • The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time : a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety(REAL)database
    Sakai R [2014]
  • The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis
    Liao KP [2015]
  • The Corrona US registry of rheumatic and autoimmune diseases
    Kremer JM [2016]
  • The CORRONA database
    Kremer J. [2005]
  • Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy : results from the KOBIO registry
    Park DJ [2017]
  • Swedish registers to examine drug safety and clinical issues in RA
    Askling J [2006]
  • Sustained rheumatoid arthritis remission is uncommon in clinical practice
    Prince FH [2012]
  • Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project
    Mercer LK [2017]
  • Serious infection across biologic-treated patients with rheumatoid arthritis : results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
  • Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)
    Hetland ML [2005]
  • Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Mercer LK [2017]
  • Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis : results from a nationwide Korean College of Rheumatology BIOlogics(KOBIO)registry
    Jung SM [2018]
  • Remission and radiographic outcome in rheumatoid arthritis : application of the 2011 ACR/EULAR remission criteria in an observational cohort
  • Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy : results from the British Society for Rheumatology Biologics Register
    Dixon WG [2006]
  • Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients
  • Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice
    Yamanaka H [2006]
  • Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis
  • Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission : a longitudinal observational study
    Lee YC [2011]
  • Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry
    Hetland ML [2014]
  • Measuring treatment impact : a review of patient-reported outcomes and other efficacy endpoints in approved product labels
    Willke RJ [2004]
  • Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice : a nationwide cohort study from Sweden
    Wadstrom H [2017]
  • Longitudinal cohort studies
    Gladman DD [2005]
  • Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research
    Curtis JR [2014]
  • Korean Observational Study Network for Arthritis(KORONA) : establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea
    Sung YK [2012]
  • Incidence of malignancy in Japanese patients with rheumatoid arthritis
    Yamada T [2011]
  • Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA
    Shidara K [2010]
  • Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study
    Kim D [2016]
  • Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors : a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety
    Komano Y [2011]
  • Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis
    Kim D [2017]
  • Impact of early diagnosis on functional disability in rheumatoid arthritis
    김담 [2017]
  • How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
    Askling J [2016]
  • Health-related quality of life of US adults with arthritis : analysis of data from the behavioral risk factor surveillance system, 2003, 2005, and 2007
    Furner SE [2011]
  • Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients(RA)in clinical practice : results from the registry of Japanese RA patients on biologics for long-term safety(REAL)registry
    Sakai R [2015]
  • Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug(DMARD)associated with frequent changes in DMARD : the CORRONA database
  • Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis
    Doyle TJ [2014]
  • First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011 : data from the NOR-DMARD register
    Lie E [2014]
  • Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint : a 5, 479-case study from the IORRA cohort
    Yano K [2018]
  • Factors associated with the use of complementary and alternative medicine for Korean patients with rheumatoid arthritis
    Han M [2015]
  • Etanercept: therapeutic use in patients with rheumatoid arthritis
    Garrison L [1999]
  • Efficient management of rheumatoid arthritis significantly reduces long-term functional disability
    Tanaka E [2008]
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2013 update
    Smolen JS [2014]
  • Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis : results from the Swedish biologics register
  • Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?
    Tutuncu Z [2006]
  • Do patients with elderly-onset rheumatoid arthritis have severe functional disability?
    Cho SK [2012]
  • Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan
    Nakajima A [2006]
  • Development of a multimorbidity index : impact on quality of life using a rheumatoid arthritis cohort
    Radner H [2015]
  • Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis
    Sung YK [2017]
  • Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis
  • Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis : results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease PJ [2017]
  • Clinical characteristics of RA patients with secondary SS and association with joint damage
    Brown LE [2015]
  • Cancer risk in patients with spondyloarthritis treated with TNF inhibitors : a collaborative study from the ARTIS and DANBIO registers
    Hellgren K [2017]
  • Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
    Michaud K [2016]
  • British society for rheumatology biologics register
    Silman A [2003]
  • Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study
    Karlson EW [2008]
  • Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
  • Association of low bone mineral density with anti-citrullinated protein antibody positivity and disease activity in established rheumatoid arthritis : findings from a US observational cohort
    Ahmad HA [2018]
  • Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity : a patient registry study
    Alemao E [2018]
  • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas : relative risks and time trends in the Swedish Biologics Register
    Askling J [2009]
  • A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries
    Curtis JR [2010]